glp-1 therapies success rate Drugs Market Size to Hit USD 132.79 Bn by 2035 GLP-1 RA prescription trends: January

Market success in metabolic disease is likely to hinge on differentiated clinical profiles, delivery innovation (especially oral formulations), and payer-aligned value strategies

WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults

ISSN 0092-8674

Heres what might be happening behind the scenes: Dry mouth (xerostomia): Dehydration is common, especially during the early stages of treatment

[11] Beyond glycemic control, certain GLP-1 receptor agonists have demonstrated significant benefits in weight management, cardiovascular risk reduction, and renal protection in patients with type 2 diabetes, though these benefits vary by specific agent

Preprint at bioRxiv (2023)